Spruce Biosciences's total assets for Q3 2024 were $65.10M, a decrease of -13.79% from the previous quarter. SPRB total liabilities were $13.46M for the fiscal quarter, a -17.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.